Skip to main content

Palla Pharma Consumer Staples

$0.295 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
5 July 2025 at 7:48am
Register to track PAL and receive email alerts.
PAL Announcements on Price Chart

Latest Announcements

Headline Date
Removal from Official List 2 August 2022 at 9:15am
Update to Shareholders - Voluntary Delisting from ASX 26 July 2022 at 3:40pm
Update to Shareholders 21 June 2022 at 4:00pm
Update to Shareholders - Declaration of shares as worthless 9 June 2022 at 10:30am
Update to Shareholders 23 May 2022 at 10:15am
Update to shareholders 21 April 2022 at 3:50pm
Update to Shareholders 29 March 2022 at 10:30am
Update to shareholders 9 March 2022 at 5:10pm
Update to shareholders 2 March 2022 at 7:15pm
Update to shareholders 16 February 2022 at 9:25am
Update to Shareholders 27 January 2022 at 11:35am
Update to Shareholders 20 January 2022 at 7:15pm
Update to shareholders 13 January 2022 at 1:10pm
Palla Pharma enters Voluntary Administration 17 December 2021 at 1:25pm
Voluntary Suspension 15 December 2021 at 8:40am
Trading Halt 13 December 2021 at 9:05am
Response to ASX Price Query 9 December 2021 at 3:10pm
Sale and Leaseback of Coolaroo Site 26 November 2021 at 10:20am
Jobkeeper Payments Notice 8 November 2021 at 2:30pm
Resignation and appointment of Chief Financial Officer 5 October 2021 at 10:25am
Investor Update Presentation Conference Call Recording 4 October 2021 at 1:30pm
Investor Update 30 September 2021 at 4:30pm
Interim Financial Report - 30 June 2021 30 September 2021 at 4:30pm
Half Year Results and Investor Update Conference Call 22 September 2021 at 10:00am
Update on lodgement of reviewed half-year financial report 9 September 2021 at 4:25pm
Extension of Reporting Deadline for Interim Financial Report 1 September 2021 at 10:05am
Appendix 4D & Preliminary Interim Report - 30 June 2021 31 August 2021 at 6:40pm
Revised Half Year Reporting Timetable & Results Presentation 30 August 2021 at 10:20am
Half Year Results Presentation and Investor Conference Call 18 August 2021 at 9:15am
European Co-Codamol submissions completed 23 June 2021 at 9:45am
Appointment of Alloga widening UK distribution network 21 June 2021 at 8:45am
Interactive recording and presentation of the 2021 AGM 27 May 2021 at 1:35pm
Results of Annual General Meeting 26 May 2021 at 5:20pm
2021 Annual General Meeting Presentation 26 May 2021 at 3:10pm
Palla Pharma Limited announces new CEO, Mr Giles Moss 26 May 2021 at 10:05am
AGM to be held virtually due to COVID-19 restrictions 25 May 2021 at 1:10pm
PAL Formal Product Launch & Production Partnership Update 4 May 2021 at 8:45am
Notice of Annual General Meeting/Proxy Form 19 April 2021 at 3:30pm
Change of Director's Interest Notice - I. Ross 13 April 2021 at 3:35pm
Change of Director's Interest Notice 31 March 2021 at 3:00pm
Change of Director's Interest Notice 31 March 2021 at 2:55pm
Appendix 2A 29 March 2021 at 12:20pm
Appendix 2A update 29 March 2021 at 12:15pm
Palla Pharma successfully completes Retail Entitlement Offer 25 March 2021 at 10:25am
Palla Pharma 2020 Corporate Governance Statement 19 March 2021 at 3:55pm
Palla Pharma 2020 Appendix 4G 19 March 2021 at 3:50pm
Palla Pharma Annual Report 19 March 2021 at 3:45pm
First Palla Pharma 30/500 Co-Codamol Caplet Order 19 March 2021 at 10:30am
Investor Update 17 March 2021 at 11:10am
Retail Entitlement Offer Booklet 9 March 2021 at 12:40pm
Register to track PAL and receive email alerts.